NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has answered complaints filed in a lawsuit four months ago by Life Technologies against it for alleged patent infringement, denying that it is infringing those patents and asserting counterclaims.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.